Obstetrics

🧬 Sexual Development

From Chromosomes to Phenotype

Anatomy and Physiology of Pregnancy

Understanding sexual development is crucial for grasping reproductive physiology and pathology. This comprehensive guide covers the journey from chromosomal determination to phenotypic expression, including key clinical correlates that frequently appear on exams.

🎯 Overview: The "Default" & The "Switch"

🎯 Fundamental Principles of Sexual Development

Key Developmental Principles:

🎯 The Golden Rule

  • The default pathway of human development is FEMALE
  • Without active signaling, embryos develop female characteristics

🎯 The Switch

  • Male development requires active signaling
  • Specifically the SRY gene and subsequent hormones
  • Without these signals, the embryo develops as female

📅 Timeline of Sexual Development Events

📅 Developmental Milestones

Key Developmental Timeline:

🎯 Week 0-5

  • Indifferent Stage: Gonads and genitalia are identical in XX and XY embryos

🎯 Week 6-7

  • Gonadal Differentiation: Testes begin to develop in XY embryos (critical window)

🎯 Week 8-9

  • Hormonal Secretion: Testes start producing Testosterone and AMH

🎯 Week 9-12

  • External Genitalia: Differentiation into male or female phenotype

🧬 Stage 1: Chromosomal Sex (Fertilization)

🧬 Genetic Determination

Determined at the moment of fertilization by the sperm.

Chromosomal Patterns:

🎯 Female

  • 46, XX

🎯 Male

  • 46, XY

⚖️ Stage 2: Gonadal Sex (The Bipotential Gonad)

⚖️ Gonadal Differentiation

Up to Week 6, the embryo has Bipotential Gonads (can become testes or ovaries).

Male Pathway (XY):

  • SRY Gene: Located on the Y chromosome (Sex-determining Region Y)
  • TDF (Testis Determining Factor): Protein encoded by SRY
  • Effect: TDF causes the bipotential gonad to differentiate into TESTES

Female Pathway (XX):

  • No Y Chromosome: Absence of SRY gene
  • Effect: Without TDF, the bipotential gonad spontaneously differentiates into OVARIES

🏗️ Stage 3: Phenotypic Sex (Internal Genitalia)

🏗️ Internal Structure Development

The embryo initially possesses both duct systems:

Initial Duct Systems:

🎯 Wolffian (Mesonephric) Ducts

  • Precursors to Male internal structures

🎯 Müllerian (Paramesonephric) Ducts

  • Precursors to Female internal structures

Male Development (Requires 2 Hormones):

The developing Testes have two key cell types that secrete specific hormones:

🎯 Sertoli Cells

  • Hormone: Anti-Müllerian Hormone (AMH)
  • Function: Causes regression (disappearance) of Müllerian ducts

🎯 Leydig Cells

  • Hormone: Testosterone
  • Function: Stimulates growth/differentiation of Wolffian ducts into internal male organs

Result: Epididymis, Vas Deferens, Seminal Vesicles

Female Development (Absence of Hormones):

  • No AMH: Müllerian ducts persist and develop
  • No Testosterone: Wolffian ducts degenerate (lack of support)
  • Result: Fallopian Tubes, Uterus, Upper Vagina

High Yield Mnemonic: Sertoli cells Shut down the female ducts (via AMH). Leydig cells Lead to male ducts (via Testosterone).

👥 Stage 4: Phenotypic Sex (External Genitalia)

👥 External Structure Development

External genitalia develop from common structures: Genital Tubercle, Urogenital Sinus, and Labioscrotal Swellings.

Key Development Factors:

🎯 Crucial Enzyme

  • 5α-Reductase

🎯 Mechanism

  • This enzyme converts Testosterone → Dihydrotestosterone (DHT)

🎯 Male Rule

  • DHT (not testosterone!) is responsible for masculinizing external genitalia

🎯 Female Rule

  • In the absence of DHT, structures follow the female pattern

Homologues Table (Very High Yield):

🎯 Embryonic Structure

  • Genital Tubercle
  • Urogenital Folds
  • Labioscrotal Swelling
  • Urogenital Sinus

🎯 Male Outcome (Driven by DHT)

  • Glans Penis
  • Ventral shaft of Penis (Encloses Urethra)
  • Scrotum (Fuses midline)
  • Prostate Gland / Bulbourethral Glands

🎯 Female Outcome (Default)

  • Glans Clitoris
  • Labia Minora
  • Labia Majora
  • Lower Vagina / Bartholin's Glands

⚕️ Clinical Correlates (Disorders of Sex Development)

⚕️ Common Clinical Presentations

1. Androgen Insensitivity Syndrome (AIS):

🎯 Karyotype

  • 46, XY

🎯 Pathology

  • Defective Androgen Receptors
  • The body produces testosterone but cannot "see" it

🎯 Presentation

  • Gonads: Testes are present (cryptorchid) because SRY worked
  • Internal: Absent. (Sertoli cells made AMH → no uterus. Leydig cells made Testosterone → but Wolffian ducts couldn't respond → no vas deferens)
  • External: Female. (Tissues couldn't respond to DHT)

🎯 Summary

  • "Looks female externally, but has testes and no uterus"

2. 5α-Reductase Deficiency:

🎯 Karyotype

  • 46, XY

🎯 Pathology

  • Cannot convert Testosterone to DHT

🎯 Presentation

  • Internal: Male (Testosterone is present, so Wolffian ducts develop)
  • External: Ambiguous/Female at birth (due to lack of DHT)
  • Puberty: Massive surge of Testosterone overrides the defect, causing virilization (penis growth, voice deepening)

🎯 Summary

  • "Penis at 12" syndrome

3. Congenital Adrenal Hyperplasia (CAH):

🎯 Karyotype

  • 46, XX

🎯 Pathology

  • 21-hydroxylase deficiency causes the adrenal gland to overproduce androgens

🎯 Presentation

  • Excess androgens masculinize the external genitalia of a female fetus

🎯 Summary

  • Ambiguous genitalia in a genetic female (clitoromegaly)

📋 Summary Checklist for Exams

📋 High-Yield Exam Points

Key Exam Points:

  • SRY determines Gonadal sex
  • Testosterone maintains Internal male ducts (Wolffian)
  • AMH removes Internal female ducts (Müllerian)
  • DHT forms External male genitalia
  • 5α-Reductase converts Testosterone to DHT